BrainStorm Cell Therapeutics
BCLI
#10400
Rank
HK$51.51 M
Marketcap
HK$4.67
Share price
0.00%
Change (1 day)
-62.02%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Total debt

Total debt on the balance sheet as of June 2025 : HK$4.48 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's total debt is HK$4.48 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

BrainStorm Cell Therapeutics - Total debt on balance sheet (from 2002 to 2025)

Total debt by year

Year Total debt Change
2024-12-31HK$5.58 M-43.87%
2023-12-31HK$9.95 M-68.86%
2022-12-31HK$31.97 M-19.25%
2021-12-31HK$39.6 M-29.21%
2020-12-31HK$55.94 M203.62%
2019-12-31HK$18.42 M
2018-12-31N/A
2010-12-31HK$1.06 M-62.84%
2009-12-31HK$2.86 M-16.2%
2008-12-31HK$3.42 M-71.51%
2007-12-31HK$12.01 M37.2%
2006-12-31HK$8.75 M
2006-03-31HK$3.86 M
2004-03-31HK$0.24 M47.42%
2003-03-31HK$0.16 M107.37%
2002-03-31HK$0.07 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Gilead Sciences
GILD
HK$194.04 B 4,322,430.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
HK$9.31 B 207,326.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
HK$0.88 B 19,568.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$51.27 B 1,142,031.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
HK$0.35 B 7,832.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA